NEW YORK (GenomeWeb) – Variantyx said today that it is integrating its clinical whole genome testing pipeline with FDNA’s Face2Gene clinical suite of phenotyping applications.

The integration enables clinicians to send information directly to Variantyx about the phenotypes, syndromes, and genes that correlate with a patient’s facial and clinical analysis. This would speed analysis and improve upon variant interpretation, Variantyx said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.